SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!
VIVUS, Inc.(NASDAQ : VVUS)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Loading VVUS News...
Health Technology » Pharmaceuticals Other
|VRX||Valeant Pharmaceuticals International, Inc.||-6.78%||22.82||3.5%||$628.87m|
|SHPG||Shire PLC Sponsored ADR||0.02%||193.49||0.4%||$368.49m|
|PRGO||Perrigo Co. Plc||0.97%||92.41||3.1%||$186.80m|
|ENDP||Endo International Plc||-2.78%||17.50||5.6%||$138.26m|
|JAZZ||Jazz Pharmaceuticals Plc||-1.10%||141.96||3.1%||$118.79m|
|ICPT||Intercept Pharmaceuticals, Inc.||3.29%||158.20||12.8%||$92.43m|
|HZNP||Horizon Pharma plc||-1.10%||18.86||11.8%||$82.22m|
|GWPH||GW Pharmaceuticals PLC Sponsored ADR||0.99%||94.68||7.7%||$67.42m|
|UTHR||United Therapeutics Corporation||-0.91%||111.41||15.4%||$65.41m|
|SAGE||SAGE Therapeutics, Inc.||2.28%||44.38||8.4%||$62.15m|
|PCRX||Pacira Pharmaceuticals, Inc.||1.89%||38.35||19.3%||$36.75m|
VIVUS, Inc. operates as a biopharmaceutical company, which develops innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health for US, European and other world markets. The company's products include Qsymia Obesity, Qsymia Sleep Apnea, Qsymia Diabetes and Avanafil. VIVUS was founded by Virgil A. Place on April 16, 1991 and is headquartered in Mountain View, CA.